RxDoctor Payments Data

Chad Heatwole, MD

Neurology · Rochester, NYNPI 1245255322

Payments from drug & device makers

$414,494in general payments, 2019–2025

Across 27 payments — averaging $15,352 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$257K
  • Pfizer$78K
  • Biogen$27K
  • Takeda Pharmaceuticals U.S.A., Inc.$21K
  • Lupin Inc.$20K
  • Harmony Biosciences LLC$11K
$23,359in research payments, 2019–2025

Across 5 payments — averaging $4671.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$12K
  • Neurocrine Biosciences, Inc.$12K

What the payments were for

  • Consulting fees$52,40799%
  • Travel & lodging$4311%
  • Food & beverage$1270%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis2$256,625
Pfizer5$77,985
Biogen10$27,477
Takeda Pharmaceuticals U.S.A., Inc.2$21,450
Lupin Inc.2$19,825
Harmony Biosciences LLC6$11,132

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$414,494 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York

Medicare billing

Part B allowed, 2024
$2,147
Medicare patients
19
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →